Key result
Insulin-resistance indices link to ~8% higher mortality once cohort-specific severity confounders resolve heterogeneity.
Why the study?
Insulin-resistance surrogate indices are increasingly proposed as prognostic markers, yet it was unclear whether their prognostic information is transportable across care settings or altered by omitting cohort-specific confounders from common adjustment sets.
Does omitting cohort-specific confounders from the common adjustment set alter the apparent transportability and heterogeneity of insulin-resistance surrogate indices (TyG, TyHGB, NHHR, TCBI) for predicting mortality across different care settings?
Cohort (n=28,520)
Yes
Does omitting cohort-specific confounders from the common adjustment set alter the apparent transportability and heterogeneity of insulin-resistance surrogate indices (TyG, TyHGB, NHHR, TCBI) for predicting mortality across different care settings?
Answers are grounded in this paper and cite their sources.
Apparent heterogeneity in the prognostic value of insulin-resistance indices across care settings is driven by residual confounding when omitting ICU severity scores (SOFA, APACHE IV), while incremental predictive value (ΔAUC) remains minimal.
Background. Insulin-resistance (IR) surrogate indices, including the triglyceride-glucose (TyG) index, are increasingly proposed as prognostic markers. Their number is expanding rapidly, yet it is unclear whether the prognostic information they carry is transportable between care settings. We examined how omitting cohort-specific confounders from the common adjustment set alters the apparent transportability of four IR surrogate indices across care settings. Methods. Multi-database cohort study in three populations: MIMIC-IV (n = 1934; 28-day ICU mortality), eICU-CRD (n = 17262; in-hospital mortality), and CHARLS 2011 (n = 9324; mortality to 2018; 2015 wave for fasting sensitivity). ICU analyses used a 24-hour landmark. TyG, TyHGB, NHHR and TCBI used identical formulas (Table S1). Cohort-specific Cox models with three adjustment levels were fitted; per-SD hazard ratios were pooled by inverse-variance meta-analysis with I² and 95% prediction intervals. Results. TyG had a positive association estimate in every cohort (HR 1.074–1.083) and TyHGB in all three (1.065–1.128; pooled 1.078, 95% CI 1.040–1.117). Primary cohort-specific adjustment yielded I² = 0% for all indices; common adjustment suggested I² of 70.2% (TyG) and 84.5% (TyHGB) (95% CIs 0–99.2% and 38.7–99.6%; overlapping with the 0% under cohort-specific adjustment). NHHR and TCBI showed I² = 0% under both strategies. Prediction intervals for TyG (0.828–1.403) and TyHGB (0.854–1.361) included unity. ΔAUC after adding individual indices ranged from − 0.0043 to 0.0053; inverse-probability weighting did not support reading unweighted ICU estimates as upper bounds. Conclusions. Under per-SD scaling, cohort-specific adjustment yielded I² = 0% for all four indices, whereas common adjustment suggested I² of 70.2% (TyG) and 84.5% (TyHGB), though 95% CIs were wide and overlapping under k = 3. Reintroducing cohort-specific confounders (SOFA, APACHE IV) returned I² to 0%, consistent with residual confounding from omitting severity measures rather than a general adjustment-choice effect. Pooled hazard ratios combine different mortality horizons and do not constitute clinical transfer. Assessment of candidate indices should distinguish measurement calibration, conditional association, fixed-rule performance and incremental prediction for a defined population and horizon.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2026) conducted a cohort in Critical illness and general community populations evaluated for mortality risk using insulin-resistance surrogate indices (n=28,520). Insulin-resistance surrogate indices (TyG, TyHGB, NHHR, and TCBI) vs. Different covariate adjustment strategies (cohort-specific adjustment including severity scores vs common adjustment omitting cohort-specific confounders) was evaluated on All-cause mortality (28-day ICU mortality in MIMIC-IV, in-hospital mortality in eICU-CRD, and mortality to 2018 in CHARLS) (HR 1.078, 95% CI 1.040-1.117). Insulin-resistance surrogate indices showed apparent heterogeneity under common adjustment that resolved to I²=0% when cohort-specific severity confounders were included.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: